Want to see INDOY full AI Analyst Report?
Top Page
Indorama Ventures
(OTC:INDOY)
Select Model
Select Model
Rating:47Neutral
Price Target:
$6.50
▼(-4.13% Downside)
Action:Reiterated
Date:08/17/26
The score is primarily held back by persistent net losses and high leverage despite improving margins and strong free-cash-flow momentum. Technicals are also weak (below key moving averages with negative MACD), while valuation is mixed—supported by a ~3.47% dividend yield but constrained by a negative P/E due to losses.
Positive Factors
Improving operating profitability
The return to positive EBIT and wider EBITDA margins indicate operational recovery across the chemical portfolio. If sustained, improved conversion economics and utilization can strengthen earnings quality even before net income fully recovers.
Negative Factors
Persistent net losses
Continued bottom-line losses show that the operating recovery has not yet translated into sustainable shareholder profitability. This can restrict reinvestment capacity, weaken equity returns and make results vulnerable to further spread or demand pressure.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving operating profitability
The return to positive EBIT and wider EBITDA margins indicate operational recovery across the chemical portfolio. If sustained, improved conversion economics and utilization can strengthen earnings quality even before net income fully recovers.
Read all positive factors
Indorama Ventures (INDOY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.81B
Dividend Yield3.33%
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)0.11
Revenue Growth-2.67%
EPS Growth-538.98%
CountryUS
Employees22,027
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-5.70
Shares Outstanding561,455,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.87
Price to Sales (P/S)0.21
P/FCF Ratio5.79
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Indorama Ventures Business Overview & Revenue Model
Company Description
Indorama Ventures Public Company Limited functions as a global manufacturer and distributor of a wide array of chemical and fiber products. Its extensive product range includes polyethylene terephthalate (PET), purified terephthalic acid (PTA), pa...
How the Company Makes Money
Indorama Ventures primarily makes money by manufacturing and selling petrochemical and polymer products across an integrated chain, with earnings largely tied to sales volumes and commodity-linked margins (spreads) between feedstocks and finished ...
Indorama Ventures Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
40
Negative
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 460.97B | 428.76B | 541.58B | 544.30B | 656.27B | 470.55B |
| Gross Profit | 60.15B | 47.78B | 75.26B | 68.26B | 114.04B | 84.98B |
| EBITDA | 36.87B | 23.43B | 22.18B | 29.47B | 76.32B | 63.81B |
| Net Income | -2.25B | -7.35B | -19.26B | -10.80B | 31.01B | 26.29B |
Balance Sheet | ||||||
| Total Assets | 566.86B | 523.73B | 541.55B | 590.13B | 623.88B | 541.83B |
| Cash, Cash Equivalents and Short-Term Investments | 39.04B | 28.00B | 19.08B | 20.79B | 23.06B | 16.46B |
| Total Debt | 280.59B | 279.16B | 262.02B | 254.33B | 254.31B | 224.23B |
| Total Liabilities | 436.76B | 409.62B | 402.62B | 412.06B | 422.99B | 370.82B |
| Stockholders Equity | 117.54B | 102.68B | 125.95B | 164.36B | 185.99B | 158.77B |
Cash Flow | ||||||
| Free Cash Flow | 32.13B | 15.49B | 17.52B | 26.90B | 49.42B | 10.57B |
| Operating Cash Flow | 47.82B | 32.64B | 35.11B | 53.13B | 77.98B | 33.77B |
| Investing Cash Flow | -16.28B | -25.55B | -21.88B | -25.65B | -74.16B | -25.77B |
| Financing Cash Flow | -13.74B | 2.52B | -14.54B | -28.91B | 1.52B | -10.89B |
Indorama Ventures Technical Analysis
Positive
6.78
Price Trends
6.80
Positive
7.11
Negative
6.53
Positive
Market Momentum
-0.04
Negative
54.12
Neutral
92.91
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For INDOY, the sentiment is Positive. The current price of 6.78 is above the 20-day moving average (MA) of 6.63, below the 50-day MA of 6.80, and above the 200-day MA of 6.53, indicating a bullish trend. The MACD of -0.04 indicates Negative momentum. The RSI at 54.12 is Neutral, neither overbought nor oversold. The STOCH value of 92.91 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INDOY.
Indorama Ventures Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
53 Neutral | $21.91B | -16.90 | -6.58% | 4.69% | -1.20% | -30.03% | |
51 Neutral | $4.92B | -4.21 | -28.81% | 0.26% | -2.28% | 27.94% | |
49 Neutral | $1.69B | -9.52 | -6.28% | 4.00% | 0.65% | 45.36% | |
49 Neutral | $876.75M | -1.56 | -40.45% | 3.21% | 3.53% | -118.53% | |
47 Neutral | $3.81B | -41.02 | -6.01% | 3.01% | -2.67% | -538.98% | |
42 Neutral | $617.04M | -0.69 | 142.56% | ― | -1.40% | 2.39% |
* Basic Materials Sector Average
INDOY
Indorama Ventures
7.35
0.81
12.32%
CE
Celanese
45.00
-2.52
-5.30%
BAK
Braskem SA
1.68
-1.80
-51.72%
HUN
Huntsman
9.47
-1.21
-11.33%
TROX
TRONOX
5.40
1.27
30.75%
DOW
Dow Inc
30.51
6.77
28.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.